Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Restenosis after coronary angioplasty

Cipollone F, Marini M, Fazia M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vase Biol 2001 21(3) 327-334. [Pg.225]

Tardif, J., Probucol and multivitamins in the prevention of restenosis after coronary angioplasty, N. Engl. Med., 337,365-372,1997. [Pg.562]

Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999 34 1512-1521. [Pg.206]

Pepine CJ, Hirshfeld JW, Macdonald RG, et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group. Circulation 1990 81 1753-1761. [Pg.206]

Jorgensen B, Simonsen S, Endresen K, et al. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids. Eur Heart J 1999 20 1407-1414. [Pg.169]

Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. N Engl J Med 1994 331 1331-1337. [Pg.169]

Is homocysteine involved in the pathogenesis of restenosis An association between homocysteine and restenosis is not unlikely, given the fact that homocysteine appears to induce inflammation, impair endothelial function, and stimulate smooth muscle proliferation all these mechanisms are potentially implicated in the development of restenosis. However, the data regarding tHcy levels and the risk of restenosis after coronary angioplasty are conflicting. Some investigators found an increased risk of restenosis after PCI in patients with high plasma levels of homocysteine, especially in patients not treated with stents (70-72), whereas others did not find any increased risk either in patients with (73-75) or without stents (76). [Pg.180]

Homocysteine-lowering therapy and restenosis after coronary angioplasty... [Pg.180]

Morita H, etal. Homocysteine as a riskfactorfor restenosis after coronary angioplasty. Thromb Haemost 2000 84( I ) 27-31. [Pg.183]

Tamai H, Katoh O, Suzuki S. Impact of tranilast on restenosis after coronary angioplasty Tranilast Restenosis Following Angioplasty Trial (TREAT) Am Heart J 1999 138 968- 975,... [Pg.192]

IpJH, FusterV Israel D, Badimon L, BadimonJ, ChesebroJH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty, J Am Coll Cardiol 1991 17(6 suppl B) 77B-88B,... [Pg.310]

Bertrand ME, Allain H, Lablanche JM. Results of a randomized trial of ticlopidine vs placebo for prevention of acute closure and restenosis after coronary angioplasty. The TACT study. Circulation 1990 82(suppl 3) 190. [Pg.312]

O Keefe JH Jr, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty, J Am Coll Cardiol 1992 I 9(7) I 597-1 600. [Pg.313]

Dehmer GJ, PopmaJJ, van den Berg EK, et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med I 988 3 I 9(12) 73 3-740,... [Pg.313]

Reis GJ, Boucher TM, Sipperly ME, et al, Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet I 989 2(8656) 177-181. [Pg.313]

Meurice T, Vallet B, Bauters C, et al, Role of endothelial cells in restenosis after coronary angioplasty, Fundam Clin Pharm 1996 10 234-242. [Pg.352]

Tanabe Y Ito E, Nakagawa I, Suzuki K. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine, IntJ Cardiol 2001 78(3)285-291. [Pg.534]

The angiotensin II receptor antagonists are being considered for the treatment of diseases other than hypertension (heart failure with or without left ventricular systolic dysfunction, during and after acute myocardial infarction, diabetic nephropathy, other forms of glomerulopathy, restenosis after coronary angioplasty, and atherosclerosis). [Pg.224]

Liu, M. W., Roubin, G. S., and King, S. B., Ill (1989). Restenosis after coronary angioplasty Potential biologic determinants and role of intimal hyperplasia. Circulation 79, 1374-1387. [Pg.397]

The glycoprotein Ilb/TITa inhibitors prevent restenosis after coronary angioplasty and are used in acute coronary syndromes (eg, unstable angina and non-Q wave acute myocardial infarction). [Pg.308]

Johansen, O., Brekke, M., Seljeflot, I., Abdelnoor, M., and Arnesen, H. (1999) n-3 Fatty Acids Do Not Prevent Restenosis After Coronary Angioplasty Result from the CART study. Coronary Angioplasty Restenosis Trial, J. Am. Coll. Cardiol. 33, 1619-1626. [Pg.220]

See other pages where Restenosis after coronary angioplasty is mentioned: [Pg.209]    [Pg.92]    [Pg.82]    [Pg.327]    [Pg.158]    [Pg.220]    [Pg.220]    [Pg.220]    [Pg.220]    [Pg.346]    [Pg.247]   
See also in sourсe #XX -- [ Pg.180 ]



SEARCH



Angioplasty

Coronary angioplasty

Coronary restenosis

Percutaneous transluminal coronary angioplasty restenosis after

Restenosis

Restenosis after angioplasty

© 2024 chempedia.info